Canaccord lowered the firm’s price target on Nevro (NVRO) to $7 from $8 and keeps a Hold rating on the shares. The firm said The company updated its adjusted EBITDA guidance for 2024 to reflect this improved leverage but kept its revenue guidance the same which implies lower-than-expected Q4/24 revenues, as the company’s end market continues to struggle and face strong competition from closed-loop technology.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NVRO:
- Nevro price target lowered to $6 from $7 at Piper Sandler
- Nevro Corp. Shows Resilience Amidst Revenue Challenges
- Nevro lowers 2024 revenue view to $400M-$405M from $435M-$445M
- Nevro reports Q3 EPS (41c), consensus (81c)
- NVRO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
